Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Line Stensig Lynggaard

7PUBLICATIONS
25CO-AUTHORS
Haematological tumoursAllergyHaematologyGene and molecular therapyCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Feb 10, 2026
Severe toxicity-free survival following acute lymphoblastic leukemia in patients aged 1-45 years: a Danish cohort study.

Camilla Grud Nielsen, Bodil Als-Nielsen, Birgitte Klug Albertsen

|Jan 29, 2024
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia.

Merete Dam, Maddalena Centanni, Lena E Friberg

|Sep 02, 2022
Cerebral sinovenous thrombosis and asparaginase re-exposure in patients aged 1-45 years with acute lymphoblastic leukaemia: A NOPHO ALL2008 study.

Mette Tiedemann Skipper, Cecilie Utke Rank, Kirsten Brunsvig Jarvis

|Aug 02, 2022
Asparaginase encapsulated in erythrocytes as second-line treatment in hypersensitive patients with acute lymphoblastic leukaemia.

Birgitte Klug Albertsen, Line Stensig Lynggaard, Kjeld Schmiegelow

|Mar 28, 2022
Asparaginase encapsulated in erythrocytes as second-line treatment in hypersensitive patients with acute lymphoblastic leukaemia.

Line Stensig Lynggaard, Goda Vaitkeviciene, Cecilia Langenskiöld

|Oct 09, 2021
Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study.

Line Stensig Lynggaard, Cecilie Utke Rank, Stefan Nygaard Hansen

Pageof 2

Frequent Collaborators

6 joint publications

Kjeld Schmiegelow

6 joint publications

Birgitte Klug Albertsen

4 joint publications

Cecilie Utke Rank

3 joint publications

Liv Andrés-Jensen

3 joint publications

Kirsten Brunsvig Jarvis

2 joint publications

Susanna Ranta

2 joint publications

Mats Heyman

1 joint publications

Rikke Linnemann Nielsen

1 joint publications

Sofie Gottschalk Højfeldt

1 joint publications

Louise Tram Henriksen

Frequent Collaborators

6 joint publications

Kjeld Schmiegelow

6 joint publications

Birgitte Klug Albertsen

4 joint publications

Cecilie Utke Rank

3 joint publications

Liv Andrés-Jensen

Top Related Videos

<em>In Ovo</em> Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
06:48

<em>In Ovo</em> Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on : Aug 01, 2025

547
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.2K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on : Feb 10, 2023

1.4K
See more related videos

Top Related Videos

<em>In Ovo</em> Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
06:48

<em>In Ovo</em> Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on : Aug 01, 2025

547
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.2K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on : Feb 10, 2023

1.4K
See more related videos